Health
United Imaging Healthcare Releases 2023 ESG Report, Advancing Mission of Equal Healthcare for All™
SHANGHAI, April 27, 2024 /PRNewswire/ -- United Imaging Healthcare (SSE:688271) has published its 2023 Environment, Social, and Governance (ESG) Report, reaffirming its mission to bring Equal Healthcare for All. This report highlights the company's advancements in corporate responsibility, intern...
2024-04-26 23:00
United Imaging Healthcare releases 2023 annual report, with revenue growth of 23.52%
Along with the publication of its 2023 annual report and the Q1 2024 report, United Imaging Healthcare released its ESG report. SHANGHAI, April 27, 2024 /PRNewswire/ -- United Imaging Healthcare (SSE:688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, h...
2024-04-26 23:00
New President Appointed for Nitto Denko Avecia Inc.
MILFORD, Mass., April 26, 2024 /PRNewswire/ -- Nitto Denko Avecia Inc. and Nitto Denko Avecia Pharma Services (Nitto Avecia), a global leader in contract development and manufacturing of oligonucleotides for the therapeutic market announced today that Tammy Cooper will be appointed President of N...
2024-04-26 21:20
370
Novel T-cell engager, CDH17 X CD3 cabotamig (ARB202) continues to explore dosing in patients with advanced gastrointestinal cancers
* The second DMC review recommends the continuation of dose escalation in the clinical trial as per protocol. * The interim safety assessment was based on the review of safety data from 18 metastatic gastrointestinal cancer patients, including patients that have tolerated multiple doses of ca...
2024-04-26 21:00
427
Ractigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC
SUZHOU, China, April 26, 2024 /PRNewswire/ -- Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application for RAG-01, a grou...
2024-04-26 21:00
423
FOSUN FOR GOOD, CREATING IMPACT: Fosun International Issued its 2023 ESG Report and the Second Climate Information Disclosures Report
HONG KONG, April 26, 2024 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group"), today issued the Environmental, Social and Governance (ESG) Report 2023 (the "ESG Report"). Facing the increasingly sever...
2024-04-26 19:34
586
OMRON Donates Some 3,200 Units of Blood Pressure Monitors to Global Blood Pressure Screening Campaign on World Hypertension Day
KYOTO, Japan, April 26, 2024 /PRNewswire/ -- OMRON Healthcare Co., Ltd. based in Muko,Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection, and ...
2024-04-26 16:00
691
Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa
SHANGHAI, April 26, 2024 /PRNewswire/ -- World Malaria Day is marked each year onApril 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly endanger...
2024-04-26 12:39
714
Hyosung TNC presents a new paradigm through sustainable bio BDO production.
SEOUL, South Korea, April 26, 2024 /PRNewswire/ -- Hyosung TNC is taking significant strides towards a sustainable future by focusing on the production of sustainable bio-based BDO. Butanediol (BDO) plays a crucial role as a chemical material not only in the production of spandex fibers like PTMG...
2024-04-26 08:00
747
Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints
* CBL-514 is the first product to treat cellulite at the raised areas. * Currently, there is no effective and safe cellulite treatment on the market. The global market for cellulite treatment is estimated to expand to $7.37 billion in 2034. * CBL-0201EFP Phase 2 study demonstrated CBL-514 sta...
2024-04-26 01:25
804
2024 ASCO | Mabwell to Present Clinical Data of 9MW2821 in Multiple Advanced Solid Tumor
SHANGHAI, April 25, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase I/II clinical study results of the novel Nectin-4-targeting ADC 9MW2821 for multiple advanced solid tumors will be presented in an ...
2024-04-25 22:00
707
Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil
* "Aiming to offer a Dengue antiviral treatment course in $100 price range" * Hyundai Bioscience decides to conduct dengue clinical trials in Brazil, which has the largest number of Dengue patients and offers a fast-track approval SEOUL, South Korea, April 25, 2024 /PRNewswire/ -- Hyundai Biosc...
2024-04-25 21:41
872
On-Device AI Healthcare Company Noul Announces 2 Clinical Performance Studies at Pan-African Malaria Conference
* miLab showed almost equivalent to WHO-certified first-degree microscopy experts: Sensitivity of 94.4%, Specificity of 98.1% * African authority on malaria diagnosis said "miLab is a potential game changer in accelerating access to parasitological confirmation" YONGIN, South Korea, April 25,...
2024-04-25 21:00
964
Antengene Announces One Oral and Three Poster Presentations at ASCO 2024
* Oral session：ATG-008 (mTORC1/2 Inhibitor) combined with PD-1 antibody in Phase II studies for cervical cancer * Three Poster presentations: Phase I/II studies for ATG-031 (anti-CD24 monoclonal antibody) and ATG-022 (Claudin 18.2 antibody-drug conjugate) and selinexor(XPO1 Inhibitor) SHANGHA...
2024-04-25 20:00
1051
Onconic Therapeutics Receives MFDS Approval for JAQBO, a New Treatment for Gastroesophageal Reflux Disease (GERD)
SEOUL, South Korea, April 25, 2024 /PRNewswire/ -- Onconic Therapeutics, a leading biotechnology company in Korea, today announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved JAQBO (zastaprazan citrate) for the treatment of erosive gastroesophageal reflux disease (GERD)...
2024-04-25 19:57
1014
Waterdrop Files Annual Report on Form 20-F for Fiscal Year 2023
BEIJING, April 25, 2024 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it filed its annual report on Form 20-F for the fiscal year ende...
2024-04-25 18:45
984
PolyU forms global partnership with ZEISS Vision Care to expand impact and accelerate market penetration of patented myopia control technology
HONG KONG, April 25, 2024 /PRNewswire/ -- The Hong Kong Polytechnic University (PolyU) is partnering with ZEISS Vision Care, one of the world's leading manufacturers of eyeglass lenses and ophthalmic instruments, to expand the global impact and speed up the market penetration of PolyU's proprieta...
2024-04-25 17:23
966
Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer
* The only solution for intractable cancer caused by mutations in the p53 gene * Planning clinical trials targeting cancer patients with no available treatment due to p53 gene mutations SEOUL, South Korea, April 25, 2024 /PRNewswire/ -- Hyundai Bioscience announced onApril 25th that its clinica...
2024-04-25 17:11
780
Bazi Bushen Capsule Became the Representative Drug of Anti-aging Chinese Medicine
SHIJIAZHUANG, China, April 25, 2024 /PRNewswire/ -- On April 21, the 3rd Traditional Chinese Medicine Anti-Aging Conference, hosted by the World Federation of Chinese Medicine Societies, was held inShijiazhuang. Yiling Pharmaceutical'sBazi Bushen capsule, as a representative drug of anti-aging i...
2024-04-25 16:07
920
GSK Advocates Importance of Adult Immunisation amongst Malaysians
KUALA LUMPUR, Malaysia, April 25, 2024 /PRNewswire/ -- As Malaysia's population shifts towards an ageing demographic, the importance of adult immunisation becomes increasingly apparent. By ensuring that individuals receive necessary vaccinations, adults can remain active, be healthy participants ...
2024-04-25 14:53
866
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 273 media titles]
2024-04-24 17:09
Most Read
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
9198
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
7771
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
5194
